Prospective, Randomized Open Trial to Evaluate the Efficacy of Highly Purified Urinary FSH Versus Recombinant FSH in Oocyte Donors Undergoing Controlled Ovarian Stimulation Based on Receptor N680S FSH Gene Polymorphism. Genodon Trial
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2017
At a glance
- Drugs Follitropin alfa (Primary) ; Urofollitropin (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms GENODON
- 01 Mar 2017 Planned End Date changed from 1 Jan 2017 to 1 Sep 2017.
- 01 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Aug 2017.
- 13 Feb 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.